Xiaozhong Qu

Preparation of Multifunctional Drug Carrier for Tumor-Specific Uptake and Enhanced Intracellular Delivery through the Conjugation of Weak Acid Labile Linker

We demonstrate that multifuctional drug carriers, e.g., polymeric micelles, for tumor-specific uptake and intracellular delivery can be generated from the pH-dependent progressive hydrolysis of a novel benzoic-imine linker in the micelle-forming amphiphilic polymer. The linker, hence the micelle, is stable at physiological pH, partially hydrolyzes at the extracellular pH of the solid tumor, and completely hydrolyzes at the endosomal pH. Meanwhile, the surface property of the micelle converts from neutral to positively charged due to the generation of amino groups from the cleavage of the imine bond at tumor pH. The ionization on the surface facilitates the cellular uptake of the micelles through the electrostatic interaction between the micelle and the cell membrane. Subsequently, at the endosomal pH, with more complete cleavage of the polymer the micellar structure dissociates, and the system becomes very membrane-disruptive, inferring an enhanced intracellular delivery capability via the endosomal pathway.

pH triggered injectable amphiphilic hydrogel containing doxorubicin and paclitaxel

Injectable hydrogel with hydrophobic microdomains for incorporating both hydrophilic and hydrophobic drugs, herein doxorubicin hydrochloride (DOX) and paclitaxel (PTX), was synthesized through dynamic bonding of glycol chitosan and benzaldehyde capped poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) via Schiffs reaction triggered by environmental pH. Rheology tests show that the inclusion of hydrophilic drug decreases the gelation time and gains more robust gel, while the addition of hydrophobic drug has opposite influences. Dual-drug release from the DOX+PTX loaded gels was observed and the release rate can be accelerated by decreasing the environmental pH from physiological (7.4) to weak acidic pH (6.8). In vivo investigation proved that the gels were able to diminish the amount of DOX in blood circulation and limit the DOX-induced cardiotoxicity. By intratumoral administration, the hydrogel-drug formulations resulted in efficient growth inhibition of subcutaneous tumor (B16F10) on C57LB/6 mouse model. The advantage of the current system for DOX+PTX combination therapy was demonstrated by a prolongation of survival time in comparison with the single drug therapy.

Dually responsive injectable hydrogel prepared by in situ cross-linking of glycol chitosan and benzaldehyde-capped PEO-PPO-PEO.

Injectable hydrogels with pH and temperature triggered drug release capability were synthesized based on biocompatible glycol chitosan and benzaldehyde-capped poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) (PEO-PPO-PEO). Aqueous solutions of the above polymers formed hydrogel under physiological conditions, allowing a desirable injectability, through the formation covalent benzoic-imine bond with pH and temperature changes. Rheological characterization demonstrated that the gelation rate and the moduli of the hydrogels were able to be tuned with chemical composition as well as pH and temperature of the polymer solution. Both hydrophobic and hydrophilic drugs could be incorporated inside the hydrogel through the in situ gel forming process and undergo a controlled release by altering pH or temperature. In vivo tests proved the formation and biocompatibility of the hydrogel in rat model.

Polymer nanotubes toward gelating organic chemicals

Crosslinked polymer nanotubes are large scale synthesized. The method is based on fast cationic polymerization using immiscible initiator nanodroplets. Nanoporous network processed from the nanotubes is superhydrophobic, which can absorb all the tested organic chemicals forming robust gels. The nanotubes are promising in the collection of spilled organic chemicals, detoxification and water treatment.

Janus Nanodisc of Diblock Copolymers

Janus nanodiscs of diblock copolymers are prepared by stepwise disassembly of PS-b-P4VP disc-stacked particles. The Janus nanodiscs are uniform in thickness and regular in contour. By preferential growth of functional materials at the positively charged P4VP side, the composition, microstructure, and performance of the Janus nanodiscs are tunable.

Large scale synthesis of Janus submicron sized colloids by wet etching anisotropic ones

Janus colloids have inspired growing interests due to their diverse potential applications. Herein, we present a facile approach to fabricate Janus submicron sized colloids by the selective etching of anisotropic colloids. Size ratio, microstructure and composition are tunable. The method can be scaled up, which is the key to further exploit practical applications.

Light-Triggered Reversible Phase Transfer of Composite Colloids

Composite colloids were prepared via grafting optically responsive spiropyran polymer brushes onto silica colloids. Similar to spiropyran, the polymer brushes undergo a reversible inversion from a hydrophobic state to a hydrophilic state upon irradiation with UV light (or vice versa by visible light). The composite colloids can thus reversibly transfer between oil and water phases, and this can be remotely triggered using light. At intermediate stages of irradiation, both hydrophobic and hydrophilic components coexist, resulting in the amphiphilic performance of the composite colloids. Such amphiphilic composite colloids can be used as particulate emulsifiers.

Ultrasound-triggered thrombolysis using urokinase-loaded nanogels

To find a way to modulate the effect of thrombolytic proteins by increasing their specificity, minimizing their adverse effect as well as lengthening their circulation time for the treatment of ischemic vascular disease holds great promise. In this work, urokinase-type plasminogen activator (uPA) was encapsulated into hollow nanogels which are generated by the reaction of glycol chitosan and aldehyde capped poly(ethylene glycol) (OHC-PEG-CHO) through a one-step approach of ultrasonic spray. The uPA-loaded nanogels, with size of 200-300 nm, have longer circulation time than that of the nude urokinase in vivo, besides the protein can be triggered to release in faster rate under diagnostic ultrasonic condition of 2 MHz, which significantly enhanced the thrombolysis of clots. The results are promising for increasing the specificity and positive effects of thrombolytic agents like recombinant tissue plasminogen activator (rt-PA) for the current treatment of ischemic vascular disease.

Dual-stimuli sensitive keratin graft PHPMA as physiological trigger responsive drug carriers

Keratin graft poly(N-(2-hydroxypropyl)methacrylamide) (K-g-PHPMA) copolymers were synthesized and characterized. On account of the thiol groups of keratin and the amphiphilicity of the graft copolymers, micelles with cleavable cross-links on a keratin core were fabricated in water. The K-g-PHPMA micelles can efficiently encapsulate doxorubicin (DOX) and can be used as a drug carrier. The DOX content in the micelles increases with the keratin content of the graft copolymers. The release of the encapsulated DOX in the micelles is sensitive to the physiological environment. Redox trigger glutathione (GSH), especially at the intracellular level, and trypsin can effectively trigger the release of the encapsulated DOX. In vitro cellular uptake experiments indicate that the DOX released from the DOX-loaded K-g-PHPMA micelles can be efficiently internalized into cells. Under higher GSH condition, the DOX shows a much faster release into the nucleus of the cells. The K-g-PHPMA copolymers have promising applications as drug carriers for enhanced intracellular drug delivery in cancer therapy.

PEG-urokinase nanogels with enhanced stability and controllable bioactivity

Protein nanogels were synthesized via a one-step reaction procedure by crosslinking urokinase with benzaldehyde bifunctionalized poly(ethylene glycol). The crosslinked architecture significantly enhances the stability of urokinase against enzyme degradation in comparison with the core–shell structural PEGylated proteins. Meanwhile, bioactivity of the urokinase incorporated in the nanogels can be adjusted by varying the chain length of the corsslinking polymer. With a shorter crosslinker the bioactivity of the uPA nanogels is seriously restricted under physiological conditions. However, the restricted bioactivity can be completely launched by either enlarging the mesh size of the nanogel by using longer crosslinkers, or treating the nanogels in endosomal conditions to dissociate the nanogel structure due to the reversible conjugation chemistry.